No products in the cart.
Long-acting cabotegravir significantly decreases incidence of HIV compared to daily oral tenofovir
1. Cabotegravir was shown to be superior to TDF-FTC in preventing HIV infection in women. 2. Both drugs were well ...
Tag: Cabotegravir
Oral HIV preexposure prophylaxis limits willingness to pay for long-acting injectable prophylaxis
1. Compared with generic oral emtricitabine-tenofovir disoproxil fumarate (F/TDF), long-acting injectable cabotegravir (CAB-LA) increased life expectancy by 28,000 QALYs. 2. ...
Cabotegravir plus rilpivirine given every 8 weeks is non-inferior to every 4 weeks for maintenance of HIV-1 viral suppression
1. At week 48, there was a similar proportion of participants with plasma HIV-1 RNA ≥ 50 copies per mL ...
License Our Award-Winning Physician-Written Medical News and Visual Abstracts
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.